MedTrace Logo

A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors

NCT01551875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2013-07-09

No results posted yet for this study

Summary

This non-interventional, prospective, multi-centric, cross-sectional study is aimed to obtain the distribution of measurements of CIMT in Indian subjects and will involve approx. 30 investigative sites from all over the country. Each investigative site will be expected to enrol 50 subjects and Carotid intima-media thickness (CIMT) values will be taken for each individual as described in the protocol.

All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.

Conditions

  • Carotid Intima- Media Thickness

Sponsors & Collaborators

Principal Investigators

  • Paurus M Irani, MD · AstraZeneca Pharma India Ltd.

  • R R Kasliwal, DM · Medanta, The Medicity, Gurgaon

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551875 on ClinicalTrials.gov